|
The Business of Biotechnology
Combining her interests in business and biology,
Julia Schüler is now responsible for all the marketing and thought leadership activities of Ernst & Young's Health Sciences/Biotech Team in Germany.
A Scientist on the Dark Side
Peter Kolchinsky writes about his experiences breaking into the business side of science and his work at Massachusetts-based RA Capital Associates, where he evaluates biotech startups.
From Conception to Commercialization
Before you dive right in,
John Higuchi, who manages start-up business ventures in the medical device and biopharmaceutical industries, suggests that you assess the potential of moving your idea from academic concept to profitable enterprise.
Breaking Into Technology Transfer
Helen Latham believes that technology transfer, despite being overshadowed in the public mind by its more glamorous cousins "venture capital" and "business development," actually forms the pipeline through which university scientific research flows into the commercial arena.
Investing in Postdoctoral Research
Postdoc Network Editor
Laure Haak describes a partnership between the private sector and public institutions that hopes to enhance the quality of research at the selected universities by using generous stipends to attract outstanding postdocs.
|